Smart Pen Opportunity Common Sensing offers Gocap, a smart cap for disposable pen-injectors that transmits dose and adherence data to a connected phone app, creating a data-driven upsell path for pharma partners seeking adherence analytics and remote monitoring capabilities.

SME Focused Growth With a small team (2-10 employees) and a Series A funding history, there is an opportunity to partner on pilot programs, co-development, or reseller arrangements that leverage their agility while scaling joint go-to-market efforts.

Regulatory Readiness ISO 13485 certification indicates a quality management system suitable for medical devices, suggesting a favorable alignment for collaborations with manufacturers and pharma companies seeking compliant digital health accessories.

Strategic Partnerships Past and ongoing partnerships with Haselmeier and leadership ties to health start-ups signal a readiness for collaboration; identify potential co-development or white-label deals with device makers and insulin/auto-injector brands.

Market Growth The company targets injectable medicine users, including diabetes and other chronic therapies; potential sales angles include bundled adherence solutions, remote monitoring, and data-driven patient support offered to tiered payer and provider networks.